Figure 1.
Eyes treated with ranibizumab (a) and eyes treated with aflibercept after changing from ranibizumab treatment (b) are categorized according to the frequency of maintenance injections
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.